Posttraumatic stress disorder, drug companies, and the internet

Journal of Trauma and Dissociation

Volumn 10, Issue 1, 2009, Pages 9-23

  Mansell, Penny ^a   Read, John ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Internet; Pharmaceutical industry; PTSD

Indexed keywords

ACCESS TO INFORMATION; ARTICLE; CONTENT ANALYSIS; DRUG INDUSTRY; DRUG MARKETING; FUNDING; HEALTH EDUCATION; INTERNET; MEDICAL INFORMATION; MEDICAL RESEARCH; MENTAL DISEASE; MENTAL HEALTH; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PUBLIC HEALTH;

ADVERTISING AS TOPIC; ATTITUDE TO HEALTH; DRUG INDUSTRY; HEALTH BEHAVIOR; HUMANS; INTERNET; MASS MEDIA; NEW ZEALAND; STRESS DISORDERS, POST-TRAUMATIC;

EID: 60749087615     PISSN: 15299732     EISSN: 15299740     Source Type: Journal    
DOI: 10.1080/15299730802488494     Document Type: Article

References (25)

1. Antonuccio, D., Danton, W. and McClanahan, T. (2003) Psychology in the prescription era: Building a firewall between marketing and science. American Psychologist, 58, pp. 1028-1043.
2. Ball, D., Tisocki, K. and Herxheimer, A. (2006) Advertising and disclosure of funding on patient organisation websites: A cross-sectional survey. BMC Public Health, 6:201, pp. 201-212.
3. Breggin, P. (2008) Medication madness: A psychiatrist exposes the dangers of mood-altering drugs, St. Martin's Press, New York
4. Davis, J., Cross, E. and Crowley, J. (2007) Pharmaceutical websites and the communication of risk information. Journal of Health Communication, 12:1, pp. 29-39.
5. de Wattignar, S. and Read, J. The pharmaceutical industry and the internet: Are drug company funded depression websites biased?. Journal of Mental Health
6. Doran, E., Kerridge, I., McNeill, P. and Henry, D. (2006) Empirical uncertainty and moral contest: A qualitative analysis of the relationship between medical specialists and the pharmaceutical industry in Australia. Social Science & Medicine, 62, pp. 1510-1519.
7. Farina, A., Fisher, J., Getter, H. and Fischer, E. (1978) Some consequences of changing people's views regarding the nature of mental illness. Journal of Abnormal Psychology, 87, pp. 272-279.
8. Fava, G. (2004) Conflict of interest in psychopharmacology: Can Dr. Jekyll still control Mr. Hyde?. Psychotherapy and Psychosomatics, 73:1, pp. 1-4.
9. Fox, N., Ward, K. and O'Rourke, A. (2005) The "expert patient": Empowerment or medical dominance? The case of weight loss, pharmaceutical drugs and the Internet. Social Science & Medicine, 60, pp. 1299-1309.
10. Griffiths, K. and Christensen, H. (2000) Quality of web based information on treatment of depression: Cross sectional survey. British Medical Journal, 321, pp. 1511-1515.
11. Healy, D. and Thase, M. (2003) Is academic psychiatry for sale?. British Journal of Psychiatry, 182, pp. 388-390.
12. Kempner, J. (2006) Gendering the migraine market: Do representations of illness matter?. Social Science & Medicine, 63, pp. 1986-1987.
13. Kisely, S., Ong, G. and Takyar, A. A. (2003) Survey of the quality of web based information on the treatment of schizophrenia and Attention Deficit Hyperactivity Disorder. Australian and New Zealand Journal of Psychiatry, 37, pp. 85-91.
14. Mather, C. (2005) The pipeline and the porcupine: Alternate metaphors of the physician-industry relationship. Social Science & Medicine, 60, pp. 1323-1334.
15. Mintzes, B. (2002) Direct to consumer advertising is medicalising normal human experience. British Medical Journal, 324, pp. 908-909.
16. Moncrieff, J. (2008) The myth of the chemical cure: A critique of psychiatric drug treatment, Palgrave Macmillan, Basingstoke, UK
17. Moncrieff, J. (2003) Is psychiatry for sale? An examination of the influence of the pharmaceutical industry on academic and practical psychiatry, Institute of Psychiatry, London
18. Moncrieff, J. and Thomas, P. (2002) The pharmaceutical industry and disease mongering: Psychiatry should not accept so much commercial sponsorship. British Medical Journal, 325, p. 218.
19. Mosher, L., Gosden, R. and Beder, S. (2004) Drug companies and schizophrenia: Unbridled capitalism meets madness. Models of madness, pp. 116-130. Routledge, London
20. Moynihan, R. and Cassels, A. (2005) Selling sickness: How the world's biggest pharmaceutical companies are turning us all into patients, Nation Books, New York
21. Powell, J. and Clarke, A. (2006) Internet information-seeking in mental health: Population survey. British Journal of Psychiatry, 189, pp. 273-277.
22. Read, J. (2008) Schizophrenia, drug companies and the Internet. Social Science & Medicine, 66, pp. 99-109.
23. Sharfstein, S. (2005) Big pharma and American psychiatry: The good, the bad and the ugly. Psychiatric News, 40:16, pp. 3-4.
24. Shooter, M. (2005) Dancing with the devil? A personal view of psychiatry's relationships with the pharmaceutical industry. Psychiatric Bulletin, 29, pp. 81-83.
25. Woodlock, D. (2005) Virtual pushers: Antidepressant Internet marketing and women. Women's Studies International Forum, 28:4, pp. 304-314.